BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12602496)

  • 1. Evaluation of mathematical models describing drug release from estradiol transdermal systems.
    Costa P; Sousa Lobo JM
    Drug Dev Ind Pharm; 2003 Jan; 29(1):89-97. PubMed ID: 12602496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro release profile of estradiol transdermal therapeutic systems.
    Tymes NW; Shah VP; Skelly JP
    J Pharm Sci; 1990 Jul; 79(7):601-2. PubMed ID: 2398467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of dissolution medium agitation on release profiles of sustained-release tablets.
    Paulo ; Sousa Lobo JM
    Drug Dev Ind Pharm; 2001 Sep; 27(8):811-7. PubMed ID: 11699832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divisability of diltiazem matrix sustained-release tablets.
    Costa P; Sousa Lobo JM
    Pharm Dev Technol; 2001 Aug; 6(3):343-51. PubMed ID: 11485176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches.
    Mehdizadeh A; Toliate T; Rouini MR; Abashzadeh S; Dorkoosh F
    Acta Pharm; 2004 Dec; 54(4):301-17. PubMed ID: 15634614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrylic resins as rate-controlling membranes in novel formulation of a nine-day 17beta-estradiol transdermal delivery system: in vitro and release modifier effect evaluation.
    Rafiee-Tehrani M; Safaii-Nikui N; Peteriet H; Beckert T
    Drug Dev Ind Pharm; 2001 May; 27(5):431-7. PubMed ID: 11448050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo wound healing performance of drug loaded electrospun composite nanofibers transdermal patch.
    Kataria K; Gupta A; Rath G; Mathur RB; Dhakate SR
    Int J Pharm; 2014 Jul; 469(1):102-10. PubMed ID: 24751731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance.
    Prasad Verma PR; Chandak AR
    Acta Pharm; 2009 Jun; 59(2):171-86. PubMed ID: 19564142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical modeling of variables involved in dissolution testing.
    Gao Z
    J Pharm Sci; 2011 Nov; 100(11):4934-42. PubMed ID: 21702052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Square root of time dependence of matrix formulations with low drug content.
    Fessi H; Marty JP; Puisieux F; Carstensen JT
    J Pharm Sci; 1982 Jul; 71(7):749-52. PubMed ID: 7120057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
    Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets.
    Gil EC; Colarte AI; Bataille B; Caraballo I
    AAPS PharmSciTech; 2007 Dec; 8(4):E115. PubMed ID: 18181536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.
    Felician WA; Ghaly ES
    Pharm Dev Technol; 2011 Oct; 16(5):536-41. PubMed ID: 20954856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols.
    Salama RO; Traini D; Chan HK; Young PM
    Eur J Pharm Biopharm; 2008 Sep; 70(1):145-52. PubMed ID: 18534832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
    Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
    Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microemulsions for topical delivery of estradiol.
    Peltola S; Saarinen-Savolainen P; Kiesvaara J; Suhonen TM; Urtti A
    Int J Pharm; 2003 Mar; 254(2):99-107. PubMed ID: 12623186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.